Human Papilloma Virus Testing Market

Future Market Insights

Key Insight

The human papilloma virus testing market is projected to grow from USD 2.0 billion in 2025 to USD 7.5 billion by 2035, at a CAGR of 14.1%. Cervical Cancer Screening will dominate with a 76.7% market share, while consumables will lead the product outlook segment with a 65.3% share.

October 07, 2025

Anurag Sharma

250 Pages

Cite this Report

Human Papilloma Virus Testing Market

https://www.futuremarketinsights.com/reports/human-papilloma-virus-testing-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Abbott
Bio-Rad Laboratories
Biomedical Diagnostics
F. Hoffmann-La Roche Ag
Fujirebio
Hologic
Oncolab
Qiagen
Siemens

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Human Papilloma Virus Testing Market

Key Players

Similar Industry Reports